INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 8,807,000 Value ($000) $7,940 Avg Close Range
Q1 2021
Shares 9,534,000 Value ($000) $7,806 Avg Close Range
Q4 2020
Shares 10,437,000 Value ($000) $8,098 Avg Close Range
Q3 2020
Shares 9,285,000 Value ($000) $7,511 Avg Close Range
Q2 2020
Shares 6,272,000 Value ($000) $4,751 Avg Close Range
Q1 2020
Shares 6,055,000 Value ($000) $4,996 Avg Close Range
Q4 2019
Shares 5,603,000 Value ($000) $5,664 Avg Close Range
Q3 2019
Shares 5,603,000 Value ($000) $4,847 Avg Close Range
Q2 2019
Shares 4,662,000 Value ($000) $4,180 Avg Close Range
Q1 2019
Shares 8,335,000 Value ($000) $8,290 Avg Close Range
Q3 2018
Shares 6,337,000 Value ($000) $6,436 Avg Close Range
Q2 2018
Shares 7,762,000 Value ($000) $6,835 Avg Close Range
Q1 2018
Shares 1,063,000 Value ($000) $857 Avg Close Range
Q4 2017
Shares 1,750,000 Value ($000) $1,400 Avg Close Range
Q3 2017
Shares 3,250,000 Value ($000) $2,527 Avg Close Range
Q4 2016
Shares 2,500,000 Value ($000) $2,241 Avg Close Range
Q3 2016
Shares 4,000,000 Value ($000) $4,493 Avg Close Range